Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver, Colorado Winship Cancer Institute of Emory University, Atlanta, Georgia The University of Kansas Cancer Center, Fairway, Kansas Rutgers Cancer Institute, New Brunswick, New Jersey Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania